Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / OrganismsTools
SugarDrawer
GlycanBuilder
Glycan Converters
GlycoMaple
GlycomeAtlas
LM-GlycomeAtlas
GALAXY
MCAW
GlycoSim
GRable
Guidelines
MIRAGE
G90387AM
Summary
- GlyTouCan ID
-
G90387AM
- IUPAC Condensed
- Neu5Ac(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(?1-
- Motifs
- 3-Sialyl-LN (type 2) Lewis x Lex SSEA-1
- Subsumption Level
- Linkage-defined saccharide
- Monoisotopic Mass
- 820.3
3D Structures
GlycoShape
Organisms
| Organisms | Evidence |
|---|---|
| Homo sapiens (human) |
Taxonomic Hierarchy
Pathway
| Pathway Name | Organism |
|---|---|
| Lewis blood group biosynthesis | Rattus norvegicus |
| Lewis blood group biosynthesis | Sus scrofa |
| Lewis blood group biosynthesis | Canis familiaris |
| Lewis blood group biosynthesis | Drosophila melanogaster |
| Lewis blood group biosynthesis | Bos taurus |
| Lewis blood group biosynthesis | Mus musculus |
| Lewis blood group biosynthesis | Caenorhabditis elegans |
| Lewis blood group biosynthesis | Homo sapiens |
| Lewis blood group biosynthesis | Xenopus tropicalis |
| Lewis blood group biosynthesis | Gallus gallus |
Sequence Descriptors
- GlycoCT
-
RES 1b:x-dglc-HEX-1:5 2s:n-acetyl 3b:a-lgal-HEX-1:5|6:d 4b:b-dgal-HEX-1:5 5b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d 6s:n-acetyl LIN 1:1d(2+1)2n 2:1o(3+1)3d 3:1o(4+1)4d 4:4o(3+2)5d 5:5d(5+1)6n
- WURCS
- WURCS=2.0/4,4,3/[a2122h-1x_1-5_2*NCC/3=O][a1221m-1a_1-5][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O]/1-2-3-4/a3-b1_a4-c1_c3-d2
Literature
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 37357420 | Toward α‐1,3/4 fucosyltransferases targeted drug discovery: In silico uncovering of promising natural inhibitors of fucosyltransferase 6 | Magdaleno JSL | 2023 Jun 25 |
|
| 37343170 | Monoclonal Antibody F2 Reactive with Sialyl Lewis x | Monoclonal Antibody F2 Reactive with Sialyl Lewis x | 2023 Jun 01 |
|
| 37057964 | Therapeutic Effects of an Anti-Sialyl Lewis x Antibody in a Murine Model of Acute Lung Injury | Liu W | 2023 Jun 01 |
|
| 37486674 | Identification of potential classes of glycoligands mediating dynamic endothelial adhesion of human tumor cells | Starzonek S | 2023 Jul 24 |
|
| 37486087 | How E-, L-, and P-Selectins Bind to sLex and PSGL-1: A Quantification of Critical Residue Interactions | Sladek V | 2023 Jul 24 |
|
| 37449872 | Synthesis of Sialyl LewisX Mimetics with E- and P-Selectin Binding Properties and Immunosuppressive Activity | Simard RD | 2023 Jul 14 |
|
| 37182470 | Revisiting the structural basis for biological activity of GMI-1070, a sialyl Lewisx mimetic | Arend LB | 2023 Jul |
|
| 36648484 | Sialyl Lewis X mediates interleukin-1 beta-induced trophoblast adhesion to endometrial cells during human embryo implantation | Ma Z | 2023 Jan 16 |
|
| 37074623 | ST3GalIV drives SLeX biosynthesis in gastrointestinal cancer cells and associates with cancer cell motility | Costa AF | 2023 Apr 19 |
|
| 36125302 | The Sialyl Lewis X Glycan Receptor Facilitates Infection of Subtype H7 Avian Influenza A Viruses | Guan M | 2022 Oct 12 |
|
